Trans-intestinal cholesterol efflux is not mediated through high density lipoprotein

Hypocholesterolemia, foam cell accumulation, but no atherosclerosis in mice lacking ABC-transporter A1 and scavenger receptor BI

(2011) Ying Zhao et al.   ATHEROSCLEROSIS

Biliary Sterol Secretion Is Not Required for Macrophage Reverse Cholesterol Transport

(2010) Ryan E. Temel et al.   Cell Metabolism

Biliary Sterol Secretion Is Required for Functional In Vivo Reverse Cholesterol Transport in Mice

(2010) Niels Nijstad et al.   GASTROENTEROLOGY

Both the Peroxisome Proliferator-Activated Receptor δ Agonist, GW0742, and Ezetimibe Promote Reverse Cholesterol Transport in Mice by Reducing Intestinal Reabsorption of HDL-Derived Cholesterol

(2009) François Briand et al.   CTS-Clinical and Translational Science

Activation of the Liver X Receptor Stimulates Trans-intestinal Excretion of Plasma Cholesterol

(2009) Jelske N. van der Veen et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Regulation of direct transintestinal cholesterol excretion in mice

(2008) Astrid E. van der Velde et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Targeted Depletion of Hepatic ACAT2-driven Cholesterol Esterification Reveals a Non-biliary Route for Fecal Neutral Sterol Loss

(2008) J. Mark Brown et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Cholesterol efflux pathways and other potential mechanisms involved in the athero-protective effect of high density lipoproteins

(2008) A. R. Tall   JOURNAL OF INTERNAL MEDICINE

The role of reverse cholesterol transport in animals and humans and relationship to atherosclerosis

(2008) Daniel J. Rader et al.   JOURNAL OF LIPID RESEARCH